Smithfield Trust’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-22
Closed 1025
2024
Q1
$0 Buy
+22
New +$1.39K ﹤0.01% 1067
2022
Q3
Sell
-19
Closed -$1K 1065
2022
Q2
$1K Hold
19
﹤0.01% 1059
2022
Q1
$1K Hold
19
﹤0.01% 1066
2021
Q4
$1K Hold
19
﹤0.01% 1063
2021
Q3
$2K Hold
19
﹤0.01% 1075
2021
Q2
$2K Hold
19
﹤0.01% 1043
2021
Q1
$3K Hold
19
﹤0.01% 1054
2020
Q4
$3K Hold
19
﹤0.01% 1030
2020
Q3
$2K Sell
19
-70
-79% -$6.04K ﹤0.01% 1036
2020
Q2
$8K Buy
89
+25
+39% +$2K ﹤0.01% 769
2020
Q1
$4K Buy
64
+19
+42% +$1.54K ﹤0.01% 802
2019
Q4
$4K Buy
+45
New +$3.96K ﹤0.01% 824

Other funds holding EXAS

Smithfield Trust's EXAS Position: Q2 2024 in Review

Smithfield Trust sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 22 shares.

Smithfield Trust first reported a position in EXAS in Q4 2019 and held it in 12 quarters. The position peaked at $8K in Q2 2020. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Smithfield Trust reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Smithfield Trust sold 22 Exact Sciences shares in Q2 2024.
  • Smithfield Trust first reported a position in Exact Sciences in Q4 2019 and held it in 12 quarters.
  • Smithfield Trust's Exact Sciences position peaked at $8K in Q2 2020.
  • 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Smithfield Trust's 13F filing for Q2 2024, filed 31 Jul 2024.